scholarly journals A survey of attitudes towards methicillin-resistant Staphylococcus aureus bacteraemias amongst United Kingdom microbiologists

2009 ◽  
Vol 65 (2) ◽  
pp. 347-349 ◽  
Author(s):  
A. Hussain ◽  
S. Alleyne ◽  
D. Jenkins
2019 ◽  
Author(s):  
S.M. McTavish ◽  
S.J. Snow ◽  
E.C. Cook ◽  
B. Pichon ◽  
S. Coleman ◽  
...  

AbstractObjectiveTo undertake the first detailed genomic analysis of methicillin-resistant Staphylococcus aureus (MRSA) isolated in Sri Lanka.MethodsA prospective observational study was performed on 94 MRSA isolates collected over a four month period from the Anuradhapura Teaching Hospital, Sri Lanka. Screening for mecA, mecC and the Panton-Valentine leucocidin (PVL)-associated lukS-PV/lukF-PV genes and molecular characterisation by spa typing was undertaken. Whole genome sequencing (WGS) and phylogenetic analysis was performed on selected multilocus sequence type (MLST) clonal complex 5 (CC5) isolates from Sri Lanka, England, Australia and Argentina.ResultsAll 94 MRSA harboured the mecA gene. Nineteen spa types associated with nine MLST clonal complexes were identified. Most isolates were from skin and soft tissue infections (76.9%), with the remainder causing more invasive disease. Sixty two (65.9%) of isolates were PVL positive with the majority (56 isolates; 90.3%) belonging to a dominant CC5 lineage. This lineage, PVL-positive ST5-MRSA-IVc, was associated with community and hospital-onset infections. Based on WGS, representative PVL-positive ST5-MRSA-IVc isolates from Sri Lanka, England and Australia formed a single phylogenetic clade, suggesting wide geographical circulation.ConclusionsWe present the most detailed genomic analysis of MRSA isolated in Sri Lanka to date. The analysis identified a PVL-positive ST5-MRSA-IVc that dominates MRSA clinical infections in Sri Lanka. Furthermore, transmission of the strain has occurred in the United Kingdom and Australia.


2002 ◽  
Vol 6 (51) ◽  
Author(s):  
S Dancer

Laboratory tests have confirmed that a patient who died last week in a hospital in, Lanarkshire, Scotland, was infected with a Glycopeptide Intermediate Resistant Staphylococcus aureus (GISA) (1). GISA has increased resistance to first line antibiotics used for treating infections caused by methicillin resistant Staphylococcus aureus (MRSA), namely, vancomycin and teicoplanin (2). This is the second report of an infection with this organism for Scotland, and possibly the first report in the United Kingdom of an associated death. (3).


2019 ◽  
Vol 57 (6) ◽  
Author(s):  
H. Ciesielczuk ◽  
M. Xenophontos ◽  
J. Lambourne

ABSTRACT Reports of methicillin-resistant Staphylococcus aureus (MRSA) harboring the mecC gene have increased in the UK since first being described. To our diagnostic S. aureus multiplex PCR, a mecC primer set was designed and implemented, and then the prevalence in our patient population was investigated. Fewer than 1% of the clinical isolates possessed the mecC gene, confirming that mecA remains the dominant genetic determinant of MRSA in East London.


Sign in / Sign up

Export Citation Format

Share Document